<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
	<ui>1743-422X-10-238</ui>
	<ji>1743-422X</ji>
	<fm>
		<dochead>Research</dochead>
		<bibl>
			<title>
				<p>Aberrant placental immune parameters in the feline immunodeficiency virus (FIV)-infected cat suggest virus-induced changes in T cell function</p>
			</title>
			<aug>
				<au id="A1"><snm>Chumbley</snm><mnm>Bart</mnm><fnm>Lyndon</fnm><insr iid="I1"/><email>lbchumbley@gmail.com</email></au>
				<au id="A2"><snm>Boudreaux</snm><mi>E</mi><fnm>Crystal</fnm><insr iid="I2"/><email>boudc@vtc.vt.edu</email></au>
				<au id="A3" ca="yes"><snm>Coats</snm><mi>S</mi><fnm>Karen</fnm><insr iid="I1"/><email>kcoats@grad.msstate.edu</email></au>
			</aug>
			<insg>
				<ins id="I1"><p>Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA</p></ins>
				<ins id="I2"><p>Virginia Tech Carilion Research Institute and School of Medicine, Roanoke, VA 24016, USA</p></ins>
			</insg>
			<source>Virology Journal</source>
			<issn>1743-422X</issn>
			<pubdate>2013</pubdate>
			<volume>10</volume>
			<issue>1</issue>
			<fpage>238</fpage>
			<url>http://www.virologyj.com/content/10/1/238</url>
			<xrefbib><pubidlist><pubid idtype="doi">10.1186/1743-422X-10-238</pubid><pubid idtype="pmpid">23870389</pubid></pubidlist></xrefbib>
		</bibl>
		<history><rec><date><day>4</day><month>2</month><year>2013</year></date></rec><acc><date><day>11</day><month>7</month><year>2013</year></date></acc><pub><date><day>19</day><month>7</month><year>2013</year></date></pub></history>
		<cpyrt><year>2013</year><collab>Chumbley et al.; licensee BioMed Central Ltd.</collab><note>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</note></cpyrt>
		<kwdg>
			<kwd>Feline immunodeficiency virus</kwd>
			<kwd>Placenta</kwd>
			<kwd>Regulatory T cells</kwd>
			<kwd>Th17 cells</kwd>
			<kwd>Cytokines</kwd>
		</kwdg>
		<abs>
			<sec>
				<st>
					<p>Abstract</p>
				</st>
				<sec>
					<st>
						<p>Background</p>
					</st><p>Immune activity during pregnancy must be tightly regulated to ensure successful pregnancy. This regulation includes the suppression of inflammatory activity that could target the semi-allogeneic fetus. Tregs are immunosuppressive; Th17 cells are pro-inflammatory. A precise balance in the two cell populations is critical to pregnancy maintenance, while dysregulation in this balance accompanies compromised pregnancy in humans and mice. FIV is known to target Tregs preferentially in the infected cat. Therefore, it may be hypothesized that FIV infection alters the placental Treg/Th17 cell balance resulting in aberrant immunomodulator expression by these cells and consequent pregnancy perturbation.</p>
				</sec>
				<sec>
					<st>
						<p>Methods</p>
					</st><p>RNA was purified from random sections of whole placental tissues collected from both uninfected and FIV-infected queens at early pregnancy, including tissues from viable and nonviable fetuses. Real time qPCR was performed to quantify expression of intranuclear markers of Tregs (FoxP3) and Th17 cells (ROR&#947;); cytokine products of Tregs (IL-10 and TGF-&#946;), Th17 cells (IL-2, IL-6, and IL-17a), and macrophages (IL-1&#946;); and the FIV gag gene. Pairwise comparisons were made to evaluate coexpression patterns between the cytokines and between the cytokines and the virus.</p>
				</sec>
				<sec>
					<st>
						<p>Results</p>
					</st><p>Both FoxP3 and ROR&#947; were reduced in placentas of infected animals. Neither infection status nor fetal viability affected placental expression of IL-1&#946;. However, fetal nonviability was associated with reduced levels of all other cytokines. Infection and fetal nonviability impacted coexpression of various cytokine pairs. No obvious bias toward Treg or Th17 cells was observed.</p>
				</sec>
				<sec>
					<st>
						<p>Conclusions</p>
					</st><p>FIV infection coupled with fetal nonviability alters expression patterns of T cell cytokines. These data suggest that functionally altered placental T cell leukocyte populations may occur in the infected queen and possibly contribute to fetal nonviability.</p>
				</sec>
			</sec>
		</abs>
	</fm>
	<bdy>
		<sec>
			<st>
				<p>Background</p>
			</st><p>New pediatric AIDS cases are on the decline globally, largely a result of antiretroviral prophylaxis reaching low and middle income countries. In 2011, the number of children acquiring HIV infection had declined by 43% since 2009. Sub-Saharan Africa, where pediatric disease has also declined, remains the most dominant site of pediatric AIDS cases, comprising 90% of new infections. <abbrgrp>
					<abbr bid="B1">1</abbr>
				</abbrgrp>. However, in the absence of antiretroviral therapy, mother-to-child transmission of HIV occurs in 15-45% of pregnancies <abbrgrp>
					<abbr bid="B2">2</abbr>
				</abbrgrp>. HIV infection of pregnant women may result in compromised pregnancy, including low birth weight babies, pre-term delivery, and enhanced incidence of spontaneous abortions <abbrgrp>
					<abbr bid="B3">3</abbr>
					<abbr bid="B4">4</abbr>
					<abbr bid="B5">5</abbr>
				</abbrgrp>. Feline immunodeficiency virus (FIV) infection in cats is a small animal model system used to study lentivirus pathogenesis and mother-to-child transmission. FIV, like HIV, infects CD4+ T cells and other cells of the immune system leading to immunosuppression and ultimately feline AIDS <abbrgrp>
					<abbr bid="B6">6</abbr>
				</abbrgrp>. FIV infection is known to impact pregnancy outcome negatively <abbrgrp>
					<abbr bid="B7">7</abbr>
					<abbr bid="B8">8</abbr>
				</abbrgrp>, possibly due to altered placental immunology resulting from FIV infection of placental tissues.</p><p>Regulatory T cells (Tregs), a CD4&#8201;+&#8201;CD25+ T cell population, are a naturally immunosuppressive lymphocyte population characterized by the intranuclear expression of the transcriptional regulator FoxP3. Tregs are susceptible to infection by HIV <abbrgrp>
					<abbr bid="B9">9</abbr>
				</abbrgrp>, potentially leading to the beneficial outcome of suppression of inflammation or, detrimentally, persistent infection (reviewed in <abbrgrp>
					<abbr bid="B10">10</abbr>
				</abbrgrp>). Likewise, feline Tregs are preferentially infected by FIV, due to increased expression of CXCR4 (the host co-receptor for FIV) on the surface of Tregs <abbrgrp>
					<abbr bid="B11">11</abbr>
				</abbrgrp>. Due to the semi-allogeneic status of the fetus within an antigenically foreign mother, fetal Tregs are necessary to promote immunological tolerance to maternal antigens <abbrgrp>
					<abbr bid="B12">12</abbr>
					<abbr bid="B13">13</abbr>
				</abbrgrp>, while maternal Tregs promote tolerance of the fetus <abbrgrp>
					<abbr bid="B14">14</abbr>
				</abbrgrp>. Successful pregnancy is associated with increased numbers of activated Tregs, while deficiency in Treg numbers and activity is associated with pregnancy failure <abbrgrp>
					<abbr bid="B15">15</abbr>
				</abbrgrp>.</p><p>Treg activity is closely tied to the activity of IL-17 producing T helper cells (Th17 cells), a proinflammatory CD4+ T cell population. The inappropriate activity of these cells is associated with autoimmunity, graft rejection, and unexplained recurrent miscarriage <abbrgrp>
					<abbr bid="B16">16</abbr>
					<abbr bid="B17">17</abbr>
				</abbrgrp>. Th17 cells perform their proinflammatory role by the secretion of cytokines including IL-6, IL-17a/f, IL-21, IL-22, TNF&#945;, and others <abbrgrp>
					<abbr bid="B18">18</abbr>
					<abbr bid="B19">19</abbr>
				</abbrgrp>. IL-17, the pleiotropic immunomodulator for which the cell population is named, acts by promoting the expression of proinflammatory cytokines in other neighboring cells. TGF-&#946; and IL-10, key cytokine products of Tregs, inhibit IL-17 expression in a dose-dependent manner <abbrgrp>
					<abbr bid="B20">20</abbr>
				</abbrgrp>. In the absence of Treg activity, Th17 cell activity is unchecked and aberrantly elevated <abbrgrp>
					<abbr bid="B18">18</abbr>
				</abbrgrp>.</p><p>We are using the FIV-infected cat model to evaluate placental expression levels of relevant cytokine targets that are produced by Tregs, Th17 cells, and other placental cell populations <abbrgrp>
					<abbr bid="B21">21</abbr>
					<abbr bid="B22">22</abbr>
					<abbr bid="B23">23</abbr>
				</abbrgrp>. IL-1&#946; is a product of placental macrophages and is a key regulator in early differentiation and differential expression of Th17 cells <abbrgrp>
					<abbr bid="B24">24</abbr>
					<abbr bid="B25">25</abbr>
					<abbr bid="B26">26</abbr>
				</abbrgrp>. IL-2, IL-6 and IL-17a are products of activated Th17 cells; IL-2 is produced broadly by activated T lymphocyte populations <abbrgrp>
					<abbr bid="B27">27</abbr>
					<abbr bid="B28">28</abbr>
				</abbrgrp>. IL-10 and TGF-&#946; are immunosuppressive products of Tregs <abbrgrp>
					<abbr bid="B29">29</abbr>
					<abbr bid="B30">30</abbr>
				</abbrgrp>.</p><p>We hypothesized that lentivirus infection in the placenta alters the normal gene expression of placental T lymphocytes resulting in aberrant leukocyte immunomodulation, placental immunopathology, and possibly compromised pregnancy. The first objective of this study was to assess the expression of pro- and anti-inflammatory cytokines relevant to Treg and Th17 cell function and the characteristic intranuclear markers of these cells (FoxP3 and ROR&#947;, respectively) in sections of whole placental tissues obtained from viable and nonviable pregnancies from FIV-infected and control queens. The second objective was to correlate FIV gag expression in placental tissues with expression of cytokine RNA to determine whether virus levels impacted (or were impacted by) particular cytokine gene expression. We found that infection caused reduced expression of FoxP3 and ROR&#947;, and that fetal nonviability was associated with reduced expression of cytokines and discordant cytokine coexpression patterns. A negative correlation between FIV gag and some cytokines occurred in placentas from infected animals. Collectively, these data suggest that dynamics or function of placental Treg and Th17 populations is disturbed during early pregnancy in FIV-infected cats, possibly predisposing nonviable pregnancy.</p>
		</sec>
		<sec>
			<st>
				<p>Results</p>
			</st>
			<sec>
				<st>
					<p>Expression of Treg and Th17 intranuclear markers in placentas</p>
				</st><p>Quantitative PCR targeting FoxP3 and ROR&#947;, intranuclear markers for activated Tregs and Th17 cells, respectively, in a random selection of placentas from the control and infected groups (Table&#160;<tblr tid="T1">1</tblr>) was performed. The expression of FoxP3 (p&#8201;=&#8201;0.008) and ROR&#947; (p&#8201;=&#8201;0.01) were both significantly reduced in the FIV-infected group (including placentas from three nonviable offspring), as compared to control animals (all viable fetuses) (Figure&#160;<figr fid="F1">1</figr>). When placentas from nonviable pregnancies were excluded from the analyses to allow comparison of viable pregnancies independently, significant reduction in expression of both genes was still evident in the infected group (p&#8201;&#8804;&#8201;0.05; data not shown).</p>
				<table id="T1">
					<title>
						<p>Table 1</p>
					</title>
					<caption>
						<p>
							<b>Placental samples assayed for T cell marker and cytokine gene expression</b>
						</p>
					</caption>
					<tgroup align="left" cols="7">
						<colspec align="left" colname="c1" colnum="1" colwidth="1*"/>
						<colspec align="left" colname="c2" colnum="2" colwidth="1*"/>
						<colspec align="center" colname="c3" colnum="3" colwidth="1*"/>
						<colspec align="center" colname="c4" colnum="4" colwidth="1*"/>
						<colspec align="center" colname="c5" colnum="5" colwidth="1*"/>
						<colspec align="center" colname="c6" colnum="6" colwidth="1*"/>
						<colspec align="center" colname="c7" colnum="7" colwidth="1*"/>
						<thead valign="top">
							<row rowsep="1">
								<entry align="left" colname="c1" morerows="1" valign="top">
									<p>
										<b>Cat number</b>
									</p>
								</entry>
								<entry align="left" colname="c2" morerows="1" valign="top">
									<p>
										<b>Queen infection status</b>
									</p>
								</entry>
								<entry align="center" colname="c3" morerows="1" valign="top">
									<p>
										<b>Fetus identification</b>
									</p>
								</entry>
								<entry align="center" colname="c4" morerows="1" valign="top">
									<p>
										<b>Placental infection status</b>
									</p>
								</entry>
								<entry align="center" colname="c5" morerows="1" valign="top">
									<p>
										<b>Fetal viability</b>
									</p>
								</entry>
								<entry align="center" colname="c6" nameend="c7" namest="c6">
									<p>
										<b>Assay</b>
									</p>
								</entry>
							</row>
							<row rowsep="1">
								<entry align="center" colname="c6">
									<p>
										<b>FoxP3/ ROR</b>
									</p>
								</entry>
								<entry align="center" colname="c7">
									<p>
										<b>Cytokines</b>
									</p>
								</entry>
							</row>
						</thead>
						<tbody valign="top">
							<row>
								<entry colname="c1" morerows="4" valign="top">
									<p>104538059</p>
								</entry>
								<entry colname="c2" morerows="4" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>C</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>D</p>
								</entry>
								<entry align="center" colname="c4"/>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>E</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>104016108</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>C</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry colname="c1" morerows="3" valign="top">
									<p>104537284</p>
								</entry>
								<entry colname="c2" morerows="3" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>C</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>D</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="1" valign="top">
									<p>104108291</p>
								</entry>
								<entry colname="c2" morerows="1" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="1" valign="top">
									<p>104083550</p>
								</entry>
								<entry colname="c2" morerows="1" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>104292779</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>E</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>104539276</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>F</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="1" valign="top">
									<p>104100373</p>
								</entry>
								<entry colname="c2" morerows="1" valign="top">
									<p>-</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>-</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>083556062</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>C</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="3" valign="top">
									<p>104058035</p>
								</entry>
								<entry colname="c2" morerows="3" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>C</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>D</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>104521126</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>D</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>104005111</p>
								</entry>
								<entry colname="c2" morerows="2" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>R</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="1" valign="top">
									<p>104280866</p>
								</entry>
								<entry colname="c2" morerows="1" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7"/>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6">
									<p>Y</p>
								</entry>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" rowsep="1" valign="top">
									<p>104111893</p>
								</entry>
								<entry colname="c2" morerows="2" rowsep="1" valign="top">
									<p>+</p>
								</entry>
								<entry align="center" colname="c3">
									<p>A</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row>
								<entry align="center" colname="c3">
									<p>B</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>V</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
							<row rowsep="1">
								<entry align="center" colname="c3">
									<p>R</p>
								</entry>
								<entry align="center" colname="c4">
									<p>+</p>
								</entry>
								<entry align="center" colname="c5">
									<p>NV</p>
								</entry>
								<entry align="center" colname="c6"/>
								<entry align="center" colname="c7">
									<p>Y</p>
								</entry>
							</row>
						</tbody>
					</tgroup>
				</table>
				<fig id="F1"><title><p>Figure 1</p></title><caption><p>Expression of FoxP3 and ROR&#947; in control (A) and infected (B) early term placental tissue</p></caption><text>
   <p><b>Expression of FoxP3 and ROR&#947; </b><b>in control and infected early term placental tissue.</b> Real time pPCR was used to quantify the expression of FoxP3 and ROR&#947; RNA in control (n&#8201;=&#8201;10) and infected (n&#8201;=&#8201;8) early term whole placental tissues. Adjusted mean Ct, represented by vertical bars, is the normalized mean Ct value subtracted from a negative endpoint (50-mean Ct). Bars are bracketed by the standard error of the mean. The data were analyzed using single factor ANOVA. P values&#8201;&#8804;&#8201;0.05 were considered significant.</p>
</text><graphic file="1743-422X-10-238-1"/></fig>
			</sec>
			<sec>
				<st>
					<p>Gene expression profiling in viable versus nonviable placental samples</p>
				</st><p>Figure&#160;<figr fid="F2">2</figr> displays gene expression profiles of pro- and anti-inflammatory cytokines for five placental groups: control queens producing viable offspring (control viable), infected queens producing viable offspring (infected viable), infected queens producing nonviable offspring (infected nonviable), all infected samples combined (all infected), and all samples from nonviable pregnancies combined (all nonviable). For statistical analyses, all groups were compared to the control viable group. There were no significant differences in IL-1&#946; gene expression between the groups (Figure&#160;<figr fid="F2">2</figr>A). A comparison of placental tissues from control viable pregnancies to infected viable pregnancies revealed that only the expression of IL-6 (Figure&#160;<figr fid="F2">2</figr>C), a pro-inflammatory cytokine crucial for the differentiation of Th17 cells, was altered, increasing significantly (p&#8201;=&#8201;0.034). (Placenta 104083550 A was not included in this analysis because it was an outlier). No other significant differences in cytokine gene expression between these two groups were detected. Treg cytokine gene expression patterns, IL-10 (Figure&#160;<figr fid="F2">2</figr>D) and TGF-&#946; (Figure&#160;<figr fid="F2">2</figr>F), and Th17 cytokine gene expression patterns, IL-6 (Figure&#160;<figr fid="F2">2</figr>C), IL-2 (Figure&#160;<figr fid="F2">2</figr>B), and IL-17a (Figure&#160;<figr fid="F2">2</figr>E), were significantly reduced when the infected nonviable group and the all nonviable group were compared to the control viable group. Comparisons of cytokine expression in all control specimens (including those from both viable and nonviable fetuses) and all infected specimens did not differ significantly (P&#8201;&gt;&#8201;0.05; data not shown). &#946;-actin expression did not differ significantly between any group (data not shown).</p>
				<fig id="F2"><title><p>Figure 2</p></title><caption><p>Expression of cytokine genes in early term placental tissue from viable and nonviable offspring from control and infected queens</p></caption><text>
   <p><b>Expression of cytokine genes in early term placental tissue from viable and nonviable offspring from control and infected queens.</b> Real time qPCR was used to quantify the expression of relevant cytokines in placental tissue. Cytokine gene expression was determined for samples from control queens producing viable offspring (control viable; n&#8201;=&#8201;16), infected queens producing viable offspring (infected viable; n&#8201;=&#8201;9), infected queens producing nonviable offspring (infected nonviable; n&#8201;=&#8201;6), all infected samples combined (all infected; n&#8201;=&#8201;15), and all samples from nonviable pregnancies combined (all nonviable; n&#8201;=&#8201;8). Adjusted mean Ct, represented by vertical bars, is the normalized mean Ct value subtracted from a negative endpoint (60-mean Ct). Bars are bracketed by the standard error of the mean. The data were analyzed using single factor ANOVA and Wilcoxon signed-rank test. The mean Ct value for each separate group was compared to the mean Ct value for the control viable group. P values&#8201;&#8804;&#8201;0.05 were considered significant. <b>(A)</b> IL-1&#946;; <b>(B)</b> IL-2; <b>(C)</b> IL-6; <b>(D)</b> IL-10; <b>(E)</b> IL-17a; <b>(F)</b> TGF-&#946;.</p>
</text><graphic file="1743-422X-10-238-2"/></fig>
			</sec>
			<sec>
				<st>
					<p>Correlation of Cytokine Expression in Whole Placental Tissue</p>
				</st><p>Correlation analyses were used to observe the pairwise relationships of cytokine expression within each cat. All cytokine expression data, along with FIV gag expression levels <abbrgrp>
						<abbr bid="B21">21</abbr>
					</abbrgrp>, were compared and the data are summarized (Figure&#160;<figr fid="F3">3</figr>). All pairwise comparisons of cytokine expression levels were positively correlated in the placentas of control queens producing viable offspring (Figure&#160;<figr fid="F3">3</figr>A). Placentas from viable infected fetuses (Figure&#160;<figr fid="F3">3</figr>B) displayed discordant (neither positively nor negatively correlated) coexpression of IL-2 versus IL-1&#946;, IL-2 versus IL-6, and TGF-&#946; versus IL-17a. In the nonviable infected group (Figure&#160;<figr fid="F3">3</figr>C) and the all infected group (Figure&#160;<figr fid="F3">3</figr>D), IL-1&#946; and coexpression of all other cytokines was discordant. IL-6 versus IL-2 coexpression was discordant in the viable infected and the nonviable infected; IL17a versus IL-2 coexpression was also discordant in the nonviable infected group (Figure&#160;<figr fid="F3">3</figr>D) but positively correlated in all other groups.</p>
				<fig id="F3"><title><p>Figure 3</p></title><caption><p>Summary of pairwise comparisons of cytokine gene expression and FIV gag expression in early term placental tissue from viable and nonviable offspring from control and infected queens</p></caption><text>
   <p><b>Summary of pairwise comparisons of cytokine gene expression and FIV gag expression in early term placental tissue from viable and nonviable offspring from control and infected queens.</b> The expression of each gene was compared to that of all other genes. <b>(A)</b> control queens producing viable offspring (control viable; n&#8201;=&#8201;16); <b>(B)</b> infected queens producing viable offspring (infected viable; n&#8201;=&#8201;9); <b>(C)</b> infected queens producing nonviable offspring (infected nonviable; n&#8201;=&#8201;6); <b>(D)</b> all infected samples combined (all infected; n&#8201;=&#8201;15). Pairwise comparisons were analyzed using Spearman rank correlation regression analysis. P values&#8201;&#8804;&#8201;0.05 were considered significant. Green&#8201;=&#8201;positive correlation; yellow&#8201;=&#8201;no correlation; and red&#8201;=&#8201;negative correlation.</p>
</text><graphic file="1743-422X-10-238-3"/></fig><p>FIV gag expression neither positively nor negatively correlated with expression of any cytokine in the infected viable (n&#8201;=&#8201;7; Figure&#160;<figr fid="F3">3</figr>B) and infected nonviable groups (n&#8201;=&#8201;6; Figure&#160;<figr fid="F3">3</figr>C). A trend toward negative correlation with some cytokines that did not reach the level of statistical significance (p&#8201;&gt;&#8201;0.05) was evident in the latter group (data not shown). When all infected placentas were combined, FIV gag was negatively correlated with the expression of IL-6, IL-10, and IL-17a (Figure&#160;<figr fid="F3">3</figr>D).</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Discussion</p>
			</st><p>The Treg/Th17 paradigm of pregnancy is rapidly emerging. Numerous reports indicate that successful pregnancy is accompanied by Treg dominance in the maternal endometrium, especially early in pregnancy, while unexplained recurrent miscarriage is associated with elevated Th17 cell activity <abbrgrp>
					<abbr bid="B15">15</abbr>
					<abbr bid="B17">17</abbr>
					<abbr bid="B20">20</abbr>
				</abbrgrp>. Using the FIV-infected cat to model mother-to-child transmission in utero, we reported that infection results in significantly higher rates of pregnancy failure than in uninfected animals <abbrgrp>
					<abbr bid="B7">7</abbr>
					<abbr bid="B8">8</abbr>
				</abbrgrp>. In addition, infection corresponds to reduced placental expression of FoxP3 at early pregnancy, indicating that infection may diminish the number or function of Tregs in these tissues <abbrgrp>
					<abbr bid="B21">21</abbr>
					<abbr bid="B23">23</abbr>
				</abbrgrp>. The preferential replication of FIV in peripheral Tregs of cats <abbrgrp>
					<abbr bid="B31">31</abbr>
					<abbr bid="B32">32</abbr>
				</abbrgrp> suggests the vulnerability of this cell population to FIV infection in placental tissues as well. There are no reports of FIV infection of Th17 cells or the fate of those cells in infected animals. However, in both HIV-infected patients <abbrgrp>
					<abbr bid="B33">33</abbr>
				</abbrgrp> and SIV-infected macaques <abbrgrp>
					<abbr bid="B34">34</abbr>
				</abbrgrp>, diminished Th17 cells accompany disease progression. In the current study, reduced placental expression of both FoxP3 and ROR&#947; in infected queens at early pregnancy suggests Treg and Th17 suppression. In a previous report, a slight decrease in ROR&#947; expression in placentas from FIV-infected queens at early pregnancy did not reach statistical significance <abbrgrp>
					<abbr bid="B23">23</abbr>
				</abbrgrp>. This discrepancy may be attributed to different methods for quantifying the two markers; in the former study, FoxP3 and ROR&#947; protein was quantified by measuring fluorescence intensity following immunofluorescence assays, rather than quantifying RNA. Moreover, while there was overlap in the placentas examined between the previous and current studies, there were differences in the tissues sampled. Inter-cat variability is a shortcoming of the feline model system, which has used outbred animals in study populations. The variability can mask subtle differences that may be of biological importance; such variability may have contributed to inconsistency between the two studies.</p><p>We also examined expression levels of some of the hallmark and less significant cytokines produced by Tregs (TGF-&#946; and IL-10), Th17 cells (IL-6 and IL-17a), activated T helper cells and Th17 cells (IL-2) and macrophages (IL-1&#946;), acknowledging that some of these cytokines are expressed by more than one of these cell types and other cell populations within the placenta, i.e. trophoblasts, NK cells, dendritic cells, B lymphocytes, and others. With the exception of IL-1&#946;, all cytokines evaluated had decreased expression when placentas from nonviable fetuses (infected nonviable and all nonviable) were compared to placentas from uninfected queens producing viable offspring. It could be surmised that decreased placental physiology associated with fetal demise, rather than altered immune parameters, may have caused this result. However, the stability of expression of IL-1&#946; and the housekeeping gene &#946;-actin renders this explanation unlikely. The affected cytokines are all T cell products. Therefore, coupled with reduced expression of the two intranuclear markers, it seems probable that diminished T cell activity accompanies pregnancy failure in the cat model.</p><p>In the placenta, the cytokines evaluated are not limited to immunomodulatory function of leukocytes. Several of them are products of syncytio- and cytotrophoblasts <abbrgrp>
					<abbr bid="B35">35</abbr>
				</abbrgrp> or endometrial tissues <abbrgrp>
					<abbr bid="B36">36</abbr>
				</abbrgrp> and play roles in placental maturation. Cytokines such as IL-6, IL-1&#946;, and TGF-&#946; promote invasion and differentiation of trophoblasts, angiogenesis of trophoblastic villi, tissue remodeling during implantation, and cell migration (reviewed in <abbrgrp>
					<abbr bid="B37">37</abbr>
				</abbrgrp>) <abbrgrp>
					<abbr bid="B36">36</abbr>
					<abbr bid="B38">38</abbr>
				</abbrgrp>. Therefore, changes in expression of IL-6 and TGF-&#946; could reflect altered trophoblast expression. We previously reported significantly decreased IL-6 expression in early term trophoblasts microdissected from placentas of nonviable pregnancies, including FIV-infected and control cats <abbrgrp>
					<abbr bid="B39">39</abbr>
				</abbrgrp>. These data suggest that the trophoblast could be the dominant source of IL-6 in the placenta. In the same study, IL-1&#946; expression in trophoblasts did not differ regardless of infection status or fetal viability, consistent with the present report. We have not examined the function or dynamics of macrophages in the feline placenta; therefore, the contribution of these cells to IL-1&#946; levels in these feline tissues is unknown. Macrophages may be infected with FIV, but replication (measured by p24 concentration in tissue culture supernatant fluid) is minimal and much less efficient than in lymphocytes <abbrgrp>
					<abbr bid="B40">40</abbr>
				</abbrgrp>. Based on this information, placental macrophage function and expression of macrophage products, such as IL-1&#946;, may be insignificantly affected by the presence of the virus.</p><p>Pairwise comparisons of cytokine expression within each individual sample were done to determine how infection status and fetal viability were associated with coexpression. This method of comparison minimized concerns about inter-cat variability by allowing us to determine relationships from each specimen independently, rather than by comparing population means. In control animals, all pairwise comparisons, including those between pro- and anti-inflammatory cytokines, were positively correlated, a finding that may reflect a balance in the two cell populations with neither dominant. This finding was somewhat unexpected because it was assumed that expression of Treg and Th17 products would be inversely proportional due to the reported reciprocal relationship between these cell populations (with Treg dominance) in normal pregnancies (reviewed in <abbrgrp>
					<abbr bid="B41">41</abbr>
				</abbrgrp>) and the long history of the Th1/Th2 paradigm that associated successful pregnancy with an anti-inflammatory placental microenvironment <abbrgrp>
					<abbr bid="B42">42</abbr>
					<abbr bid="B43">43</abbr>
					<abbr bid="B44">44</abbr>
					<abbr bid="B45">45</abbr>
				</abbrgrp>. On the other hand, the discordant coexpression (neither a positive nor a negative correlation) of IL-2 and IL-6 in infected groups suggests the potential for imbalance in the Treg and Th17 populations. The two populations differentiate from a common progenitor CD4+ T cell population. IL-6, in concert with TGF-&#946;, drives the differentiation of Th17 cells, while IL-6 blocks differentiation of Tregs <abbrgrp>
					<abbr bid="B30">30</abbr>
					<abbr bid="B46">46</abbr>
					<abbr bid="B47">47</abbr>
				</abbrgrp>. IL-2, a product of activated T helper cells, inhibits the differentiation of CD4+ progenitor cells into mature Th17 cells while expanding the population of Tregs <abbrgrp>
					<abbr bid="B48">48</abbr>
				</abbrgrp>. IL-2 is constitutively expressed at low levels by differentiating, but not mature Th17 cells <abbrgrp>
					<abbr bid="B49">49</abbr>
				</abbrgrp>. Thus, the increase in IL-6 in placentas from infected viable fetuses (Figure&#160;<figr fid="F2">2</figr>C), along with the stable TGF-&#946; (Figure&#160;<figr fid="F2">2</figr>F) and IL-2 (Figure&#160;<figr fid="F2">2</figr>B) expression in this group, had the potential to create a Th17 dominant environment. We did not find evidence of such a result. While the expression patterns of Treg and Th17 cytokines were not clearly predictive of a functional outcome in the placentas, the hallmark cytokines TGF-&#946; and IL-17a, respectively, were discordantly coexpressed in this same group. When fetuses were nonviable, placental coexpression of IL-2 and IL-17a was aberrant. When infected groups included nonviable offspring (infected nonviable and all infected), IL-1&#946; expression was discordant with all other cytokines. This result is most likely because expression of all other cytokines was significantly affected by fetal nonviability while IL-1&#946; expression remained stable, producing a cytokine imbalance. These results indicate that infection may have perturbed Treg and/or Th17 populations, consistent with the reduction in expression of their respective intranuclear markers, FoxP3 and ROR&#947;. A plausible explanation for this occurrence is that even in an environment that would favor Th17 cells, FIV infection reduces the two populations either by direct replication in the cells <abbrgrp>
					<abbr bid="B31">31</abbr>
					<abbr bid="B32">32</abbr>
				</abbrgrp> or in a manner similar to the reduction that occurs with HIV or SIV disease progression <abbrgrp>
					<abbr bid="B33">33</abbr>
					<abbr bid="B34">34</abbr>
				</abbrgrp>.</p><p>Another putative placental cell population that may play a role in altered placental immunity in the FIV-infected cat model is the uterine NK (uNK) cell. The greatest concentration of leukocytes in the placenta (30-40% of all stromal cells) is present during early pregnancy, and 70% of those leukocytes are uNK cells. These cells play an important role in proper spiral artery remodeling and extravillous trophoblast invasion (reviewed in <abbrgrp>
					<abbr bid="B50">50</abbr>
				</abbrgrp>). Much of the placental RNA isolated in this study may be derived from this cell population. Our data indicate significant changes in expression of IL-1&#946;, IL-10, and TGF-&#946;, also uNK products. Exploration of the role of uNK cells in placental immunopathology in the FIV-infected cat model was beyond the scope of the present study, but it is an obvious direction for future research.</p><p>FIV gag RNA was detected in representative placental tissues from queens included in this study <abbrgrp>
					<abbr bid="B21">21</abbr>
				</abbrgrp>. FIV gag and cytokine gene expression neither positively nor negatively correlated in infected viable and infected nonviable groupings, suggesting that cytokine expression levels may not have impacted virus replication or vice versa. However, we saw a trend toward a negative correlation that did not reach significance in the infected nonviable group (n&#8201;=&#8201;6; data not shown); yet, when all infected specimens were combined (n&#8201;=&#8201;13), FIV gag versus IL-6, IL-10, and IL-17a were negatively correlated. Most likely the increased statistical power gained from the inclusion of more samples in the analysis revealed a negative impact of viral infection on cytokine gene expression. The mechanism of infection-induced pregnancy failure is unresolved, but placental immunopathology in the infected animal is a likely contributor.</p>
		</sec>
		<sec>
			<st>
				<p>Conclusions</p>
			</st><p>Reduced FoxP3 and ROR&#947; and aberrant cytokine expression provide evidence of Treg and Th17 cell dysfunction in the placentas of FIV-infected cats, particularly those associated with fetal nonviability. Isolation of these cells to obtain pure populations for gene expression analyses is essential to determine with precision the direct impact of infection on the cell dynamics. We attempted to microdissect these cells from frozen placental specimens to extract their RNA for gene expression analyses, but we were unsuccessful in obtaining sufficient intact RNA to achieve this goal. Given the current understanding of the importance of these cell populations on pregnancy outcome, the vulnerability of these cells to lentivirus infection, and the negative impact of lentiviral infection on fetal viability, additional study of the impact of maternal lentivirus infections on placental Treg and Th17 cell dynamics is warranted.</p>
		</sec>
		<sec>
			<st>
				<p>Methods</p>
			</st>
			<sec>
				<st>
					<p>Animals and virus</p>
				</st><p>Female cats (<it>Felis domesticus</it>) were reproductively mature and specific pathogen-free (SPF). The animals were obtained from a commercial cattery. Ten cats were inoculated intravenously with feline plasma (1&#160;mL) containing FIV-B-2542 at approximately 1 &#215; 10<sup>4</sup> virions per mL; ten uninoculated cats were used as controls <abbrgrp>
						<abbr bid="B7">7</abbr>
					</abbrgrp>. Whole blood needed for plasma and peripheral blood leukocytes was collected into Vacutainer&#174; tubes containing heparin; whole blood needed for serum was collected into Vacutainer&#174; tubes without anti-coagulant. Animals were bled at weekly to monthly intervals until delivery of kittens. FIV infection was confirmed by performing standard PCR targeting the FIV gag gene and serology to detect FIV specific antibodies <abbrgrp>
						<abbr bid="B8">8</abbr>
					</abbrgrp>. Queens were allowed to breed naturally with SPF males. Pregnancies were confirmed by ultrasonography at week 3&#8211;4 gestation (early term), then fetuses were delivered by cesarean section. Inoculated animals had been infected from 9.5 to 13.5&#160;months (mean 11.4&#160;months) at the time of delivery. Fetal and placental tissues were collected from all animals, snap frozen in liquid nitrogen, and stored at &#8722;80&#176;C. Infected animals were euthanized following delivery; control cats were spayed and released for adoption after recovery. All animal use was approved by the Institutional Animal Care and Use Committee of Mississippi State University. Animal tissues used in these studies are identified in Table&#160;<tblr tid="T1">1</tblr>.</p>
			</sec>
			<sec>
				<st>
					<p>RNA extraction from whole placental tissue</p>
				</st><p>All manipulations of frozen placental tissue were performed under RNAse free conditions. Total RNA was isolated from whole tissue samples by placing 50&#8211;100&#160;mg of thawed placental tissue into Eppendorf tubes and adding 1.0&#160;mL of Trizol Reagent (Invitrogen, Carlsbad, CA). Tissue was homogenized with a sterile pestle for 5&#160;min. Two hundred &#956;L of chloroform were added; the tubes were shaken and then vortexed vigorously for 15&#160;sec, and tubes were allowed to incubate at room temperature for 2&#8211;3&#160;min. The tubes were centrifuged for 15&#160;min at 12,000 &#215; g and 4&#176;C in a MX-305 High Speed Refrigerated Micro Centrifuge (Tomy, Menlo Park, CA). The aqueous phase was transferred to a new tube, and 0.5&#160;mL of isopropanol was added. The tubes were incubated at room temperature for 10&#160;min and then centrifuged for 10&#160;min at 12,000 &#215; g and 4&#176;C. The RNA pellet was washed twice with 1.0&#160;mL of 75% ethanol followed by centrifugation at 7,500 &#215; g. The supernatant was removed and the RNA pellet was air dried for 5&#8211;10&#160;minutes and then redissolved in DEPC-treated water. Dissolved RNA concentration was determined using a NanoDrop 1000 (Thermo Scientific, Waltham, MA) and stored at &#8722;20&#176;C.</p>
			</sec>
			<sec>
				<st>
					<p>cDNA conversion</p>
				</st><p>Isolated RNA was converted to cDNA using a High Capacity Reverse Transcription cDNA conversion kit (Applied Biosystems, Carlsbad, CA). RNA in the amount of 1.0-2.0&#160;&#956;g was diluted in 10&#160;&#956;L of DEPC-treated water and added to a reverse transcription mixture containing: 2&#160;&#956;L 2X RT buffer, 0.8&#160;&#956;L of 25X dNTP mix, 1.0&#160;&#956;L of reverse transcriptase, 2.0&#160;&#956;L of random primers, 1.0&#160;&#956;L RNase inhibitor, and 3.2&#160;&#956;L of DEPC-treated water. Reverse transcription was carried out in reaction volumes of 20&#160;&#956;L using the following protocol: 25&#176;C for 10&#160;min, 37&#176;C for 120&#160;min, 85&#176;C for 5&#160;sec.</p>
			</sec>
			<sec>
				<st>
					<p>Quantification of immunomodulator expression</p>
				</st><p>cDNA was used in quantitative PCR (qPCR) to quantify expression of relevant pro- and anti-inflammatory cytokines IL-1&#946;, IL-2, IL-6, IL-10, IL-17a, and TGF-&#946;, Th17 cell marker ROR&#947;T, Treg cell marker FoxP3, FIV gag, and &#946;-actin. One &#956;L of 20X Taqman Gene Expression Assay, 9&#160;&#956;L (500&#160;ng) of cDNA template (in Rnase-free water), and 10&#160;&#956;L of 2X Taqman gene expression master mix were added to 96-well optical plates (Applied Biosystems). All PCR reactions were performed in triplicate. Individual primers and probes present in the Taqman Gene Expression Assays are presented in Table&#160;<tblr tid="T2">2</tblr>. A 2-stage qPCR program was used: 50&#176;C for 2&#160;min and 95&#176;C for 10&#160;min, followed by 95&#176;C for 15&#160;sec and 60&#176;C for 1&#160;min (40&#160;cycles). Individual immunomodulator and viral marker Ct values were normalized to &#946;-actin, and the normalized Ct values were subtracted from a negative end point to invert the data for ease of interpretation. FIV gag gene expression was previously reported <abbrgrp>
						<abbr bid="B21">21</abbr>
					</abbrgrp>.</p>
				<table id="T2">
					<title>
						<p>Table 2</p>
					</title>
					<caption>
						<p>
							<b>Primer/probe sequences used in gene expression assays</b>
						</p>
					</caption>
					<tgroup align="left" cols="3">
						<colspec align="left" colname="c1" colnum="1" colwidth="1*"/>
						<colspec align="left" colname="c2" colnum="2" colwidth="1*"/>
						<colspec align="left" colname="c3" colnum="3" colwidth="1*"/>
						<thead valign="top">
							<row rowsep="1">
								<entry colname="c1">
									<p>
										<b>Gene</b>
									</p>
								</entry>
								<entry colname="c2">
									<p>
										<b>Primer/Probe</b>
									</p>
								</entry>
								<entry colname="c3">
									<p>
										<b>Sequence (5&#8242;-3&#8242;)</b>
									</p>
								</entry>
							</row>
						</thead>
						<tfoot>
							<p>FAM&#8201;=&#8201;6-carboxyfluorescein; fluorophore; ZEN&#8201;=&#8201;5&#8242; quencher; ABkFQ&#8201;=&#8201;Iowa Black FQ; 3&#8242; quencher.</p>
						</tfoot>
						<tbody valign="top">
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>&#946;-actin</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/ATG GAG AAG /ZEN/ATCTGGCACCACACCTT/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>ATCGAACACGGC ATT GTCACCAAC</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>AGT CAT CTT CTC ACGGTTGGCCTT</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>IL-1&#946;</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56&#8242;FAM/AAA GAG CCT /ZEN/GGTGCTGTCTGG CTC AGA/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>TGATGCAGC CAT ACAGTCACAGGA</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>CAAAGCTCATGCGGAACACCACTT</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>IL-2</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/ACT CGTCAC /ZEN/AAA CAG TGCACCTGCTT/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>TAACCTCAA CTC CTGCCACCACAA</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>TTG CTC CAG CTGTTGCTGTGTTTC</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>IL-6</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/AACCGT AGA /ZEN/AGTTGGCCTGCAGCT AA/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>TCC AGA TGCTGAAGCGTAAGGGAA</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>AAGGGT GAG GTG ATT GTTGTGTGC</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>IL-10</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/ACCAGGTCC /ZEN/TTGCTG GAG GACTTT AA/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>TTTCAAACCAAGGAC GAG CTGCAC</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>AACTGGATCATCTCGGACAAGGCT</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>IL-17a</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/GTGAGGACA /ZEN/GGA ATA GCATTCCCA CA/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>TCC CAT TCAGTT CCC ATC ACT GCT</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>TCGGTAGTTGGG CAT CCTGGATTT</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>TGF-&#946;</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/AGCAATAAT /ZEN/TCCTGGCGCTAC CTC AGC A/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>AGCACGTGGAGCTGTACC AGA AAT</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>TCCAGTGACATC AAA GGA CAG CCA</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>Gag</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/AAGAACAAC /ZEN/AAG CAG AAGCAA GAT TTGCAC/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>CAG GGTGCGCTG CAG ATA AAG AAA</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>ATG CTC TAC ACT GCATCC TAG CTG</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" valign="top">
									<p>FoxP3</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/AGC CTA CAC /ZEN/AAA TGCTTTGTGCGG GT/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>GGTTCACACGCATGTTTGCCTTCT</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>ACT CGA ATT CAT CCACGGTCCACA</p>
								</entry>
							</row>
							<row>
								<entry colname="c1" morerows="2" rowsep="1" valign="top">
									<p>ROR&#947;T</p>
								</entry>
								<entry colname="c2">
									<p>Probe</p>
								</entry>
								<entry colname="c3">
									<p>/56-FAM/AGA AATGCC /ZEN/TTGCCG TAG GGATGT CT/31ABkFQ/</p>
								</entry>
							</row>
							<row>
								<entry colname="c2">
									<p>Forward</p>
								</entry>
								<entry colname="c3">
									<p>AACCGTTGCCAACACTGTCGATTG</p>
								</entry>
							</row>
							<row rowsep="1">
								<entry colname="c2">
									<p>Reverse</p>
								</entry>
								<entry colname="c3">
									<p>ACGCCATGCCACTCTACA ACT CAA</p>
								</entry>
							</row>
						</tbody>
					</tgroup>
				</table>
			</sec>
			<sec>
				<st>
					<p>Statistical analysis</p>
				</st><p>Both Wilcoxon signed rank test (<url>http://www.wessa.net</url>) and single factor ANOVA were used to compare gene expression levels in all sample groups. Spearman rank correlation was performed to assess the pairwise relationship of cytokines and viral RNA expression (<url>http://www.wessa.net</url>). In all analyses, p values&#8201;&#8804;&#8201;0.05 were considered significant.</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Competing interests</p>
			</st><p>The authors declare that they have no competing interests.</p>
		</sec>
		<sec>
			<st>
				<p>Authors&#8217; contributions</p>
			</st><p>LBC performed all experiments, collected and analyzed data, assisted with data interpretation, and drafted the manuscript. CEB assisted with experimental design and the performance of qPCR, aided in the interpretation of data, and critically evaluated the manuscript. KSC conceived of the study, secured funding, assisted with analysis and interpretation of data, and finalized the manuscript. All authors read and approved the final manuscript.</p>
		</sec>
	</bdy>
	<bm>
		<ack>
			<sec>
				<st>
					<p>Acknowledgements</p>
				</st><p>We thank Dr. Bridget Willeford and Jamie Allison for veterinary assistance and Dr. Mark Welch for the use of equipment. This project was supported by the National Institutes of Health project # 1R21AI088187-01A1 and 2R15AI048410-02A1.</p>
			</sec>
		</ack>
		<refgrp><bibl id="B1"><aug><au><cnm>Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report</cnm></au></aug><source>UNAIDS report on the global AIDS epidemic</source><pubdate>2012</pubdate><note>
   <url>http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_enpdf</url>
</note></bibl><bibl id="B2"><aug><au><cnm>WHO</cnm></au></aug><source>HIV/AIDS: Mother-to-child transmission of HIV</source><pubdate>2012</pubdate><note>
   <url>http://www.who.int/hiv/topics/mtct/en/</url>
</note></bibl><bibl id="B3"><title><p>Impact of maternal HIV-1 infection on perinatal outcome</p></title><aug><au><snm>Kumar</snm><fnm>RM</fnm></au><au><snm>Uduman</snm><fnm>SA</fnm></au><au><snm>Khurranna</snm><fnm>AK</fnm></au></aug><source>Int J Gynaecol Obstet</source><pubdate>1995</pubdate><volume>49</volume><fpage>137</fpage><lpage>143</lpage></bibl><bibl id="B4"><title><p>Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection</p></title><aug><au><snm>Langston</snm><fnm>C</fnm></au><au><snm>Lewis</snm><fnm>DE</fnm></au><au><snm>Hammill</snm><fnm>HA</fnm></au><au><snm>Popek</snm><fnm>EJ</fnm></au><au><snm>Kozinetz</snm><fnm>CA</fnm></au><au><snm>Kline</snm><fnm>MW</fnm></au><au><snm>Hanson</snm><fnm>IC</fnm></au><au><snm>Shearer</snm><fnm>WT</fnm></au></aug><source>J Infect Dis</source><pubdate>1995</pubdate><volume>172</volume><fpage>1451</fpage><lpage>1460</lpage></bibl><bibl id="B5"><title><p>Association between HIV in pregnancy and antiretroviral therapy including protease inhibitors and low birth weight infants</p></title><aug><au><snm>Goldstein</snm><fnm>P</fnm></au><au><snm>Smit</snm><fnm>R</fnm></au><au><snm>Stevens</snm><fnm>M</fnm></au><au><snm>Sever</snm><fnm>JL</fnm></au></aug><source>Infect Dis Obstet Gyn</source><pubdate>2000</pubdate><volume>8</volume><fpage>94</fpage><lpage>98</lpage></bibl><bibl id="B6"><title><p>Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen</p></title><aug><au><snm>Bendinelli</snm><fnm>M</fnm></au><au><snm>Pistello</snm><fnm>M</fnm></au><au><snm>Lombardi</snm><fnm>S</fnm></au><au><snm>Poli</snm><fnm>A</fnm></au><au><snm>Garzelli</snm><fnm>C</fnm></au><au><snm>Matteucci</snm><fnm>D</fnm></au><au><snm>Ceccherini-Nelli</snm><fnm>L</fnm></au><au><snm>Malvaldi</snm><fnm>G</fnm></au><au><snm>Tozzini</snm><fnm>F</fnm></au></aug><source>Clin Microbiol Rev</source><pubdate>1995</pubdate><volume>8</volume><fpage>87</fpage><lpage>112</lpage></bibl><bibl id="B7"><title><p>Placental immunopathology and pregnancy failure in the FIV-infected cat</p></title><aug><au><snm>Weaver</snm><fnm>CC</fnm></au><au><snm>Burgess</snm><fnm>SC</fnm></au><au><snm>Nelson</snm><fnm>PD</fnm></au><au><snm>Wilkinson</snm><fnm>M</fnm></au><au><snm>Ryan</snm><fnm>PL</fnm></au><au><snm>Nail</snm><fnm>CA</fnm></au><au><snm>Kelly-Quagliana</snm><fnm>KA</fnm></au><au><snm>May</snm><fnm>ML</fnm></au><au><snm>Reeves</snm><fnm>RK</fnm></au><au><snm>Boyle</snm><fnm>CR</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Placenta</source><pubdate>2005</pubdate><volume>26</volume><fpage>138</fpage><lpage>147</lpage></bibl><bibl id="B8"><title><p>Maternal hematological and virological characteristics during early feline immunodeficiency virus (FIV) infection of cats as predictors of fetal infection and reproductive outcome at early gestation</p></title><aug><au><snm>Boudreaux</snm><fnm>CE</fnm></au><au><snm>Lockett</snm><fnm>NN</fnm></au><au><snm>Chemerys</snm><fnm>DN</fnm></au><au><snm>Clay</snm><fnm>BT</fnm></au><au><snm>Scott</snm><fnm>VL</fnm></au><au><snm>Willeford</snm><fnm>B</fnm></au><au><snm>Brown</snm><fnm>T</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Vet Immunol Immunopathol</source><pubdate>2009</pubdate><volume>131</volume><fpage>290</fpage><lpage>297</lpage></bibl><bibl id="B9"><title><p>Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection</p></title><aug><au><snm>Antons</snm><fnm>AK</fnm></au><au><snm>Wang</snm><fnm>R</fnm></au><au><snm>Oswald-Richter</snm><fnm>K</fnm></au><au><snm>Tseng</snm><fnm>M</fnm></au><au><snm>Arendt</snm><fnm>CW</fnm></au><au><snm>Kalams</snm><fnm>SA</fnm></au><au><snm>Unutmaz</snm><fnm>D</fnm></au></aug><source>J Immunol</source><pubdate>2008</pubdate><volume>180</volume><fpage>764</fpage><lpage>773</lpage></bibl><bibl id="B10"><title><p>The split personality of regulatory T cells in HIV infection</p></title><aug><au><snm>Chevalier</snm><fnm>MF</fnm></au><au><snm>Weiss</snm><fnm>L</fnm></au></aug><source>Blood</source><pubdate>2013</pubdate><volume>121</volume><fpage>29</fpage><lpage>37</lpage></bibl><bibl id="B11"><title><p>In vivo depletion of CD4&#8201;+&#8201;CD25+ regulatory T cells in cats</p></title><aug><au><snm>Smithberg</snm><fnm>SR</fnm></au><au><snm>Fogle</snm><fnm>JE</fnm></au><au><snm>Mexas</snm><fnm>AM</fnm></au><au><snm>Reckling</snm><fnm>SK</fnm></au><au><snm>Lankford</snm><fnm>SM</fnm></au><au><snm>Tompkins</snm><fnm>MB</fnm></au><au><snm>Dean</snm><fnm>GA</fnm></au></aug><source>J Immunol Methods</source><pubdate>2008</pubdate><volume>329</volume><fpage>81</fpage><lpage>91</lpage></bibl><bibl id="B12"><title><p>Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero</p></title><aug><au><snm>Mold</snm><fnm>JE</fnm></au><au><snm>Michaelsson</snm><fnm>J</fnm></au><au><snm>Burt</snm><fnm>TD</fnm></au><au><snm>Muench</snm><fnm>MO</fnm></au><au><snm>Beckerman</snm><fnm>KP</fnm></au><au><snm>Busch</snm><fnm>MP</fnm></au><au><snm>Lee</snm><fnm>T-H</fnm></au><au><snm>Nixon</snm><fnm>DF</fnm></au><au><snm>McCune</snm><fnm>JM</fnm></au></aug><source>Science</source><pubdate>2008</pubdate><volume>322</volume><fpage>1562</fpage><lpage>1565</lpage></bibl><bibl id="B13"><title><p>Regulation of T cell responses in the developing human fetus</p></title><aug><au><snm>Michaelsson</snm><fnm>J</fnm></au><au><snm>Mold</snm><fnm>JE</fnm></au><au><snm>McCune</snm><fnm>JM</fnm></au><au><snm>Nixon</snm><fnm>DF</fnm></au></aug><source>J Immunol</source><pubdate>2006</pubdate><volume>176</volume><fpage>5741</fpage><lpage>5748</lpage></bibl><bibl id="B14"><title><p>Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance</p></title><aug><au><snm>Kahn</snm><fnm>DA</fnm></au><au><snm>Baltimore</snm><fnm>D</fnm></au></aug><source>PNAS</source><pubdate>2010</pubdate><volume>107</volume><fpage>9299</fpage><lpage>9304</lpage></bibl><bibl id="B15"><title><p>Decidual and peripheral blood CD4&#8201;+&#8201;CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases</p></title><aug><au><snm>Sasaki</snm><fnm>Y</fnm></au><au><snm>Sakai</snm><fnm>M</fnm></au><au><snm>Miyazaki</snm><fnm>S</fnm></au><au><snm>Higuma</snm><fnm>S</fnm></au><au><snm>Shiozaki</snm><fnm>A</fnm></au><au><snm>Saito</snm><fnm>S</fnm></au></aug><source>Mol Hum Reprod</source><pubdate>2004</pubdate><volume>10</volume><fpage>347</fpage><lpage>353</lpage></bibl><bibl id="B16"><title><p>The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease</p></title><aug><au><snm>Afzali</snm><fnm>B</fnm></au><au><snm>Lombardi</snm><fnm>G</fnm></au><au><snm>Lechler</snm><fnm>RI</fnm></au><au><snm>Lord</snm><fnm>GM</fnm></au></aug><source>Clin Exp Immunol</source><pubdate>2007</pubdate><volume>148</volume><fpage>32</fpage><lpage>46</lpage></bibl><bibl id="B17"><title><p>Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion</p></title><aug><au><snm>Liu</snm><fnm>Y-S</fnm></au><au><snm>Wu</snm><fnm>L</fnm></au><au><snm>Tong</snm><fnm>X-H</fnm></au><au><snm>Wu</snm><fnm>L-M</fnm></au><au><snm>He</snm><fnm>G-P</fnm></au><au><snm>Zhou</snm><fnm>G-X</fnm></au><au><snm>Luo</snm><fnm>L-H</fnm></au><au><snm>Luan</snm><fnm>H-B</fnm></au></aug><source>Am J Reprod Immunol</source><pubdate>2011</pubdate><volume>65</volume><fpage>503</fpage><lpage>511</lpage></bibl><bibl id="B18"><title><p>CD4+ regulatory T cells control TH17 responses in a stat3-dependent manner</p></title><aug><au><snm>Chaudhry</snm><fnm>A</fnm></au><au><snm>Rudra</snm><fnm>D</fnm></au><au><snm>Treuting</snm><fnm>P</fnm></au><au><snm>Samstein</snm><fnm>RM</fnm></au><au><snm>Liang</snm><fnm>Y</fnm></au><au><snm>Kas</snm><fnm>A</fnm></au><au><snm>Rudensky</snm><fnm>AY</fnm></au></aug><source>Science</source><pubdate>2009</pubdate><volume>326</volume><fpage>986</fpage><lpage>991</lpage></bibl><bibl id="B19"><title><p>Th17 cells: a new fate for differentiating helper T cells</p></title><aug><au><snm>Chen</snm><fnm>Z</fnm></au><au><snm>O&#8217;Shea</snm><fnm>J</fnm></au></aug><source>Immunol Res</source><pubdate>2008</pubdate><volume>41</volume><fpage>87</fpage><lpage>102</lpage></bibl><bibl id="B20"><title><p>The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage</p></title><aug><au><snm>Wang</snm><fnm>W-J</fnm></au><au><snm>Hao</snm><fnm>C-F</fnm></au><au><snm>Qu</snm><fnm>Q-L</fnm></au><au><snm>Wang</snm><fnm>X</fnm></au><au><snm>Qiu</snm><fnm>L-H</fnm></au><au><snm>Lin</snm><fnm>Q-D</fnm></au></aug><source>Hum Reprod</source><pubdate>2010</pubdate><volume>25</volume><fpage>2591</fpage><lpage>2596</lpage></bibl><bibl id="B21"><title><p>Expression of regulatory T cell (Treg) activation markers in endometrial tissues from early and late pregnancy in the feline immunodeficiency virus (FIV)-infected cat</p></title><aug><au><snm>Lockett</snm><fnm>NN</fnm></au><au><snm>Scott</snm><fnm>VL</fnm></au><au><snm>Boudreaux</snm><fnm>CE</fnm></au><au><snm>Clay</snm><fnm>BT</fnm></au><au><snm>Pruett</snm><fnm>SB</fnm></au><au><snm>Ryan</snm><fnm>PL</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Placenta</source><pubdate>2010</pubdate><volume>31</volume><fpage>796</fpage><lpage>802</lpage></bibl><bibl id="B22"><title><p>Cytokine dysregulation in early- and late-term placentas from feline immunodeficiency virus (FIV)-infected cats</p></title><aug><au><snm>Scott</snm><fnm>VL</fnm></au><au><snm>Boudreaux</snm><fnm>CE</fnm></au><au><snm>Lockett</snm><fnm>NN</fnm></au><au><snm>Clay</snm><fnm>BT</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Am J Reprod Immunol</source><pubdate>2011</pubdate><volume>65</volume><fpage>480</fpage><lpage>491</lpage></bibl><bibl id="B23"><title><p>Imbalance of placental regulatory T cell and Th17 cell population dynamics in the FIV-infected pregnant cat</p></title><aug><au><snm>Boudreaux</snm><fnm>CE</fnm></au><au><snm>Chumbley</snm><fnm>LB</fnm></au><au><snm>Scott</snm><fnm>VL</fnm></au><au><snm>Wise</snm><fnm>DA</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Virol J</source><pubdate>2012</pubdate><volume>9</volume><fpage>88</fpage></bibl><bibl id="B24"><title><p>The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta</p></title><aug><au><snm>Hazuda</snm><fnm>DJ</fnm></au><au><snm>Lee</snm><fnm>JC</fnm></au><au><snm>Young</snm><fnm>PR</fnm></au></aug><source>J Biol Chem</source><pubdate>1988</pubdate><volume>263</volume><fpage>8473</fpage><lpage>8479</lpage></bibl><bibl id="B25"><title><p>Critical regulation of early Th17 cell differentiation by interleukin-1 signaling</p></title><aug><au><snm>Chung</snm><fnm>Y</fnm></au><au><snm>Chang</snm><fnm>SH</fnm></au><au><snm>Martinez</snm><fnm>GJ</fnm></au><au><snm>Yang</snm><fnm>XO</fnm></au><au><snm>Nurieva</snm><fnm>R</fnm></au><au><snm>Kang</snm><fnm>HS</fnm></au><au><snm>Ma</snm><fnm>L</fnm></au><au><snm>Watowich</snm><fnm>SS</fnm></au><au><snm>Jetten</snm><fnm>AM</fnm></au><au><snm>Tian</snm><fnm>Q</fnm></au><au><snm>Dong</snm><fnm>C</fnm></au></aug><source>Immunity</source><pubdate>2009</pubdate><volume>30</volume><fpage>576</fpage><lpage>587</lpage></bibl><bibl id="B26"><title><p>Characterization of cytokine production by human term placenta macrophages in vitro</p></title><aug><au><snm>Pavlov</snm><fnm>O</fnm></au><au><snm>Pavlova</snm><fnm>O</fnm></au><au><snm>Ailamazyan</snm><fnm>E</fnm></au><au><snm>Selkov</snm><fnm>S</fnm></au></aug><source>Am J Reprod Immunol</source><pubdate>2008</pubdate><volume>60</volume><fpage>556</fpage><lpage>567</lpage></bibl><bibl id="B27"><title><p>IL-6: regulator of Treg/Th17 balance</p></title><aug><au><snm>Kimura</snm><fnm>A</fnm></au><au><snm>Kishimoto</snm><fnm>T</fnm></au></aug><source>Eur J Immunol</source><pubdate>2010</pubdate><volume>40</volume><fpage>1830</fpage><lpage>1835</lpage></bibl><bibl id="B28"><title><p>Profile of Th17 cytokines (IL-17, TGF-&#946;, IL-6) and Th1 cytokine (IFN-&#947;) in patients with immune thrombocytopenic purpura</p></title><aug><au><snm>Ma</snm><fnm>D</fnm></au><au><snm>Zhu</snm><fnm>X</fnm></au><au><snm>Zhao</snm><fnm>P</fnm></au><au><snm>Zhao</snm><fnm>C</fnm></au><au><snm>Li</snm><fnm>X</fnm></au><au><snm>Zhu</snm><fnm>Y</fnm></au><au><snm>Li</snm><fnm>L</fnm></au><au><snm>Sun</snm><fnm>J</fnm></au><au><snm>Peng</snm><fnm>J</fnm></au><au><snm>Ji</snm><fnm>C</fnm></au><au><snm>Hou</snm><fnm>M</fnm></au></aug><source>Ann Hematol</source><pubdate>2008</pubdate><volume>87</volume><fpage>899</fpage><lpage>904</lpage></bibl><bibl id="B29"><title><p>Potential role for interleukin-10 in the immunosuppression associated with kala azar</p></title><aug><au><snm>Holaday</snm><fnm>BJ</fnm></au><au><snm>Pompeu</snm><fnm>MM</fnm></au><au><snm>Jeronimo</snm><fnm>S</fnm></au><au><snm>Texeira</snm><fnm>MJ</fnm></au><au><snm>Sousa</snm><fnm>AA</fnm></au><au><snm>Vasconcelos</snm><fnm>AW</fnm></au><au><snm>Pearson</snm><fnm>RD</fnm></au><au><snm>Abrams</snm><fnm>JS</fnm></au><au><snm>Locksley</snm><fnm>RM</fnm></au></aug><source>J Clin Invest</source><pubdate>1993</pubdate><volume>92</volume><fpage>2626</fpage><lpage>2632</lpage></bibl><bibl id="B30"><title><p>TGF&#946; in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells</p></title><aug><au><snm>Veldhoen</snm><fnm>M</fnm></au><au><snm>Hocking</snm><fnm>RJ</fnm></au><au><snm>Atkins</snm><fnm>CJ</fnm></au><au><snm>Locksley</snm><fnm>RM</fnm></au><au><snm>Stockinger</snm><fnm>B</fnm></au></aug><source>Immunity</source><pubdate>2006</pubdate><volume>24</volume><fpage>179</fpage><lpage>189</lpage></bibl><bibl id="B31"><title><p>Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors</p></title><aug><au><snm>Joshi</snm><fnm>A</fnm></au><au><snm>Garg</snm><fnm>H</fnm></au><au><snm>Tompkins</snm><fnm>MB</fnm></au><au><snm>Tompkins</snm><fnm>WA</fnm></au></aug><source>J Virol</source><pubdate>2005</pubdate><volume>79</volume><fpage>4965</fpage><lpage>4976</lpage></bibl><bibl id="B32"><title><p>Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation</p></title><aug><au><snm>Joshi</snm><fnm>A</fnm></au><au><snm>Vahlenkamp</snm><fnm>TW</fnm></au><au><snm>Garg</snm><fnm>H</fnm></au><au><snm>Tompkins</snm><fnm>WA</fnm></au><au><snm>Tompkins</snm><fnm>MB</fnm></au></aug><source>Virology</source><pubdate>2004</pubdate><volume>321</volume><fpage>307</fpage><lpage>322</lpage></bibl><bibl id="B33"><title><p>HIV-1 diseases progression associated with loss of Th17 cells in subtype &#8216;C&#8217; infection</p></title><aug><au><snm>Singh</snm><fnm>A</fnm></au><au><snm>Vajpayee</snm><fnm>M</fnm></au><au><snm>Ali</snm><fnm>SA</fnm></au><au><snm>Mojumdar</snm><fnm>K</fnm></au><au><snm>Chauhan</snm><fnm>NK</fnm></au><au><snm>Singh</snm><fnm>R</fnm></au></aug><source>Cytokine</source><pubdate>2012</pubdate><volume>60</volume><fpage>55</fpage><lpage>63</lpage></bibl><bibl id="B34"><title><p>Paucity of IL-21&#8211;producing CD4+ T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques</p></title><aug><au><snm>Micci</snm><fnm>L</fnm></au><au><snm>Cervasi</snm><fnm>B</fnm></au><au><snm>Ende</snm><fnm>ZS</fnm></au><au><snm>Iriele</snm><fnm>RI</fnm></au><au><snm>Reyes-Aviles</snm><fnm>E</fnm></au><au><snm>Vinton</snm><fnm>C</fnm></au><au><snm>Else</snm><fnm>J</fnm></au><au><snm>Silvestri</snm><fnm>G</fnm></au><au><snm>Ansari</snm><fnm>AA</fnm></au><au><snm>Villinger</snm><fnm>F</fnm></au><etal/></aug><source>Blood</source><pubdate>2012</pubdate><volume>120</volume><fpage>3925</fpage><lpage>3935</lpage></bibl><bibl id="B35"><title><p>Network of cytokines, integrins and hormones in human trophoblast cells</p></title><aug><au><snm>Das</snm><fnm>C</fnm></au><au><snm>Kumar</snm><fnm>VS</fnm></au><au><snm>Gupta</snm><fnm>S</fnm></au><au><snm>Kumar</snm><fnm>S</fnm></au></aug><source>J Reprod Immunol</source><pubdate>2002</pubdate><volume>53</volume><fpage>257</fpage><lpage>268</lpage></bibl><bibl id="B36"><title><p>Transforming growth factor beta regulates proliferation and invasion of rat placental cell lines</p></title><aug><au><snm>Lafontaine</snm><fnm>L</fnm></au><au><snm>Chaudhry</snm><fnm>P</fnm></au><au><snm>Lafleur</snm><fnm>M-J</fnm></au><au><snm>Van Themsche</snm><fnm>C</fnm></au><au><snm>Soares</snm><fnm>MJ</fnm></au><au><snm>Asselin</snm><fnm>E</fnm></au></aug><source>Biol Reprod</source><pubdate>2011</pubdate><volume>84</volume><fpage>553</fpage><lpage>559</lpage></bibl><bibl id="B37"><title><p>Interleukin-6 in pregnancy and gestational disorders</p></title><aug><au><snm>Prins</snm><fnm>JR</fnm></au><au><snm>Gomez-Lopez</snm><fnm>N</fnm></au><au><snm>Robertson</snm><fnm>SA</fnm></au></aug><source>J Reprod Immunol</source><pubdate>2012</pubdate><volume>95</volume><fpage>1</fpage><lpage>14</lpage></bibl><bibl id="B38"><title><p>Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast</p></title><aug><au><snm>Husslein</snm><fnm>H</fnm></au><au><snm>Haider</snm><fnm>S</fnm></au><au><snm>Meinhardt</snm><fnm>G</fnm></au><au><snm>Prast</snm><fnm>J</fnm></au><au><snm>Sonderegger</snm><fnm>S</fnm></au><au><snm>Kn&#246;fler</snm><fnm>M</fnm></au></aug><source>Placenta</source><pubdate>2009</pubdate><volume>30</volume><fpage>284</fpage><lpage>291</lpage></bibl><bibl id="B39"><title><p>Immunomodulator expression in trophoblasts from the feline immunodeficiency virus (FIV)-infected cat</p></title><aug><au><snm>Scott</snm><fnm>VL</fnm></au><au><snm>Shack</snm><fnm>LA</fnm></au><au><snm>Eells</snm><fnm>JB</fnm></au><au><snm>Ryan</snm><fnm>PL</fnm></au><au><snm>Donaldson</snm><fnm>JR</fnm></au><au><snm>Coats</snm><fnm>KS</fnm></au></aug><source>Virol J</source><pubdate>2011</pubdate><volume>8</volume><fpage>336</fpage></bibl><bibl id="B40"><title><p>CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells</p></title><aug><au><snm>Reggeti</snm><fnm>F</fnm></au><au><snm>Ackerley</snm><fnm>C</fnm></au><au><snm>Bienzle</snm><fnm>D</fnm></au></aug><source>J Gen Virol</source><pubdate>2008</pubdate><volume>89</volume><fpage>277</fpage><lpage>287</lpage></bibl><bibl id="B41"><title><p>Cytokines in recurrent pregnancy loss</p></title><aug><au><snm>Saini</snm><fnm>V</fnm></au><au><snm>Arora</snm><fnm>S</fnm></au><au><snm>Yadav</snm><fnm>A</fnm></au><au><snm>Bhattacharjee</snm><fnm>J</fnm></au></aug><source>Clin Chim Acta</source><pubdate>2011</pubdate><volume>412</volume><fpage>702</fpage><lpage>708</lpage></bibl><bibl id="B42"><title><p>Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes</p></title><aug><au><snm>El-Shazly</snm><fnm>S</fnm></au><au><snm>Makhseed</snm><fnm>M</fnm></au><au><snm>Azizieh</snm><fnm>F</fnm></au><au><snm>Raghupathy</snm><fnm>R</fnm></au></aug><source>Am J Reprod Immunol</source><pubdate>2004</pubdate><volume>52</volume><fpage>45</fpage><lpage>52</lpage></bibl><bibl id="B43"><title><p>Elevated Th1/Th2 cell ratios in a pregnant woman with a history of RSA, secondary Sj&#246;gren&#8217;s syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy</p></title><aug><au><snm>Kwak-Kim</snm><fnm>J</fnm></au><au><snm>Lee</snm><fnm>S-K</fnm></au><au><snm>Gilman-Sachs</snm><fnm>A</fnm></au></aug><source>Am J Reprod Immunol</source><pubdate>2007</pubdate><volume>58</volume><fpage>325</fpage><lpage>329</lpage></bibl><bibl id="B44"><title><p>Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions</p></title><aug><au><snm>Makhseed</snm><fnm>M</fnm></au><au><snm>Raghupathy</snm><fnm>R</fnm></au><au><snm>Azizieh</snm><fnm>F</fnm></au><au><snm>Omu</snm><fnm>A</fnm></au><au><snm>Al-Shamali</snm><fnm>E</fnm></au><au><snm>Ashkanani</snm><fnm>L</fnm></au></aug><source>Hum Reprod</source><pubdate>2001</pubdate><volume>16</volume><fpage>2219</fpage><lpage>2226</lpage></bibl><bibl id="B45"><title><p>Synthesis of T helper 2-type cytokines at the maternal-fetal interface</p></title><aug><au><snm>Lin</snm><fnm>H</fnm></au><au><snm>Mosmann</snm><fnm>TR</fnm></au><au><snm>Guilbert</snm><fnm>L</fnm></au><au><snm>Tuntipopipat</snm><fnm>S</fnm></au><au><snm>Wegmann</snm><fnm>TG</fnm></au></aug><source>J Immunol</source><pubdate>1993</pubdate><volume>151</volume><fpage>4562</fpage><lpage>4573</lpage></bibl><bibl id="B46"><title><p>Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells</p></title><aug><au><snm>Bettelli</snm><fnm>E</fnm></au><au><snm>Carrier</snm><fnm>Y</fnm></au><au><snm>Gao</snm><fnm>W</fnm></au><au><snm>Korn</snm><fnm>T</fnm></au><au><snm>Strom</snm><fnm>TB</fnm></au><au><snm>Oukka</snm><fnm>M</fnm></au><au><snm>Weiner</snm><fnm>HL</fnm></au><au><snm>Kuchroo</snm><fnm>VK</fnm></au></aug><source>Nature</source><pubdate>2006</pubdate><volume>441</volume><fpage>235</fpage><lpage>238</lpage></bibl><bibl id="B47"><title><p>Transforming growth factor-[beta] induces development of the TH17 lineage</p></title><aug><au><snm>Mangan</snm><fnm>PR</fnm></au><au><snm>Harrington</snm><fnm>LE</fnm></au><au><snm>O&#8217;Quinn</snm><fnm>DB</fnm></au><au><snm>Helms</snm><fnm>WS</fnm></au><au><snm>Bullard</snm><fnm>DC</fnm></au><au><snm>Elson</snm><fnm>CO</fnm></au><au><snm>Hatton</snm><fnm>RD</fnm></au><au><snm>Wahl</snm><fnm>SM</fnm></au><au><snm>Schoeb</snm><fnm>TR</fnm></au><au><snm>Weaver</snm><fnm>CT</fnm></au></aug><source>Nature</source><pubdate>2006</pubdate><volume>441</volume><fpage>231</fpage><lpage>234</lpage></bibl><bibl id="B48"><title><p>Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation</p></title><aug><au><snm>Laurence</snm><fnm>A</fnm></au><au><snm>Tato</snm><fnm>CM</fnm></au><au><snm>Davidson</snm><fnm>TS</fnm></au><au><snm>Kanno</snm><fnm>Y</fnm></au><au><snm>Chen</snm><fnm>Z</fnm></au><au><snm>Yao</snm><fnm>Z</fnm></au><au><snm>Blank Rebecca</snm><fnm>B</fnm></au><au><snm>Meylan</snm><fnm>F</fnm></au><au><snm>Siegel</snm><fnm>R</fnm></au><au><snm>Hennighausen</snm><fnm>L</fnm></au><etal/></aug><source>Immunity</source><pubdate>2007</pubdate><volume>26</volume><fpage>371</fpage><lpage>381</lpage></bibl><bibl id="B49"><title><p>Persistence of IL-2 expressing Th17 cells in healthy humans and experimental autoimmune uveitis</p></title><aug><au><snm>Yu</snm><fnm>C-R</fnm></au><au><snm>Oh</snm><fnm>H-M</fnm></au><au><snm>Golestaneh</snm><fnm>N</fnm></au><au><snm>Amadi-Obi</snm><fnm>A</fnm></au><au><snm>S. Lee</snm><fnm>Y</fnm></au><au><snm>Eseonu</snm><fnm>A</fnm></au><au><snm>Mahdi</snm><fnm>RM</fnm></au><au><snm>Egwuagu</snm><fnm>CE</fnm></au></aug><source>Eur J Immunol</source><pubdate>2011</pubdate><volume>41</volume><fpage>3495</fpage><lpage>3505</lpage></bibl><bibl id="B50"><title><p>Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua</p></title><aug><au><snm>Lash</snm><fnm>GE</fnm></au><au><snm>Robson</snm><fnm>SC</fnm></au><au><snm>Bulmer</snm><fnm>JN</fnm></au></aug><source>Placenta</source><pubdate>2010</pubdate><volume>31</volume><fpage>S87</fpage><lpage>S92</lpage></bibl></refgrp>
	</bm>
</art>